Stem cell-derived self-organizing three-dimensional organoids have emerged as a novel medical innovation to recapitulate respiratory diseases. This clinical research and systematic review was conducted for systematically reviewing the clinical pharmacotherapeutics of alveolar organoids, with thorough explanations and analyses of the medical study literature and evidence compiled from the different studies conducted, thus authenticating the multi-dimensional pharmacomolecular significance of alveolar organoids. The objective of this clinical research was an observational descriptive analytical research study and a systematic review on the clinical pharmacotherapeutics of alveolar organoids. The study was conducted in accordance with the PRISMA (Preferred Reporting Items for Systematic reviews and Meta-Analyses) Statement and Guidelines, 2009, described by the Cochrane Collaboration in June, 2016. At first, the steps of identification included the records which were identified through database searching and the additional records which were identified through other sources. This led to the steps of screening, which included the screened records, after the duplicates were removed. From these screened records, few records were excluded, as per the exclusion criteria. Then, in the eligibility step, the full text articles were assessed for eligibility, from which few full text articles were excluded, according to the exclusion criteria, with adequate reasons. This led to the final inclusion step, where the studies were included in the qualitative synthesis of a systematic review, according to the inclusion criteria, and ultimately the studies were included in the quantitative synthesis. An observational descriptive analytical research study was also conducted on the clinical pharmacotherapeutics of alveolar organoids. This systematic review, performed in accordance with the PRISMA (Preferred Reporting Items for Systematic reviews and Meta-Analyses) Statement and Guidelines, 2009, described by the Cochrane Collaboration, June, 2016, contributed 28 refined and relevant medical records, among total 37 records obtained from the study databases search. It also describes and thoroughly analyses the clinical pharmacotherapeutics of alveolar organoids which validates, clarifies, and elaborates this clinical research and systematic review.To conclude, this clinical research and systematic review provided the refined qualitatively synthesised medical records, study literature and databases on the clinical pharmacotherapeutics of alveolar organoids, with an explanatory observational descriptive analysis.
Citation: Moumita Hazra (2022) An Observational Descriptive Analytical Research Study and a Systematic Review on the Clinical Pharmacotherapeutics of Alveolar Organoids, International Journal of Public Health, Pharmacy and Pharmacology, Vol. 7, No.2, pp.1-8
Keywords: Pharmacology, Systematic Review, alveolar organoids, clinical pharmacotherapeutics, clinical research, observational descriptive analysis, respiratory medicine
